GlobalData on MSN
Massive Bio partners with OpenAI to broaden clinical trial access
Through working with OpenAI, Massive Bio converts complex clinical trial criteria into machine-readable formats.
Company secures $5M in funding to accelerate its rapid testing platformUSP Validation achieved, reinforcing 20-hour testing methodFaster test results replace the standard 14-day USP sterility test SAN ...
Pivot Bio debuted two new centers in the St. Louis area that are intended to accelerate its crop nutrition innovation and U.S ...
14d
Opna Bio Announces Fast Track Designation Granted to OPN-6602 for the Treatment of Multiple Myeloma
OPN-6602 Currently Treating Patients in Phase 1 Clinical Trial SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--April 15, 2026-- Opna Bio, a clinical-s ...
This oncology-focused biotech, advancing multiple clinical-stage therapeutics, just reported a notable insider sale in recent filings.
Climb Bio Inc (NASDAQ:CLYM) is one of the tiny stocks that are on fire right now. On April 7, Climb Bio received FDA Fast ...
Every small business owner should have a short, succinct bio that can be used for various purposes. The bio should be authoritative and positive, and should reflect your level of professional ...
A new extruded foam made from polybutylene succinate (PBS), developed by the Fraunhofer Cluster of Excellence Circular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results